CAREERS
Transform drug discovery with us
ZielBio is looking for passionate, talented individuals to join our team as we work to revolutionize the treatment of cancer and other serious diseases.
Our vision
ZielBio is committed to revolutionizing the treatment of as yet incurable diseases using groundbreaking technology that reveals actionable insights to develop new therapeutic modalities to meaningfully improve patients’ lives.
Join us
Are you looking for an exciting career opportunity with the potential to transform drug discovery? Check for career opportunities below.
Associate Director, Project Management
APPLY NOW
Associate Director, Project Management
- M.S./Ph.D. in a scientific-related field
- At least five years in the pharmaceutical/biotechnology industry
- At least 3 years’ experience in project management
- Solid understanding of drug discovery and early development
- Experience in using project management tools
- Excellent communication and interpersonal skills, time/resource management, attention to detail, and proven success working in matrix environments
SUMMARY:
The Project Manager is responsible for managing the resources, timelines and budgets for discovery and early translational programs at ZielBio.
RESPONSIBILITIES:
- Work with scientific leads and head of program management to identify critical path activities, milestones, gaps and challenges and develop plans accordingly to meet program goals.
- Clearly and timely communicate timeline expectations, changes, issues or relevant information to managers and colleagues as appropriate.
- Implement strategies for keeping track of internal and external scientific activities and timelines; track those activities.
- Manage contractual aspects of nonclinical external collaborations.
- Establish collaborative relationships with external vendors and communicate proactively when potential issues/challenges arise on studies and/or timelines are not being met.
ABOUT ZIELBIO:
ZielBio is an early-stage biotechnology company that identifies novel high value disease targets and develops therapeutic interventions to improve patient outcomes. ZielBio has a rich pipeline. Its lead candidate ZB131 is currently in the clinic and is a proprietary humanized monoclonal antibody against cell surface plectin (CSP), a target that is highly expressed on the plasma membrane of multiple types of cancer cells, including ovarian, pancreatic, lung, and colorectal.
